awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
1
Q28075305-2A649168-6D61-4512-9C6B-3180108B127A
Q28075305-2A649168-6D61-4512-9C6B-3180108B127A
BestRank
Statement
http://www.wikidata.org/entity/statement/Q28075305-2A649168-6D61-4512-9C6B-3180108B127A
Angiogenesis Inhibitors for the Treatment of Hepatocellular Carcinoma
P2860
Q28075305-2A649168-6D61-4512-9C6B-3180108B127A
BestRank
Statement
http://www.wikidata.org/entity/statement/Q28075305-2A649168-6D61-4512-9C6B-3180108B127A
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
53dbb7e0c063904e0eff269df609ba4e8038f92f
P2860
Allosteric MEK1/2 inhibitor refametinib (BAY 86-9766) in combination with sorafenib exhibits antitumor activity in preclinical murine and rat models of hepatocellular carcinoma.